Cencora Inc

COR

Equity

ISIN null / Valor 1212868

New York Stock Exchange, Inc (2025-11-14)

USD 361.94-0.96%

Cencora Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Cencora Inc is a software development company specializing in creating custom solutions for businesses.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

For the third quarter of fiscal 2025, Cencora Inc achieved $80.7 billion in revenue, marking an 8.7% increase compared to the same period last year. This growth was driven by an 8.5% rise in the U.S. Healthcare Solutions segment and a 10.5% increase in the International Healthcare Solutions segment.

Earnings Per Share

Cencora Inc reported a GAAP diluted EPS of $3.52 and an adjusted diluted EPS of $4.00 for the third quarter of fiscal 2025, representing a 45.5% and 19.8% increase respectively compared to the prior year quarter.

Guidance Update

The company has raised its adjusted diluted EPS guidance for fiscal year 2025 to a range of $15.85 to $16.00, up from the previous range of $15.70 to $15.95, reflecting improved financial expectations.

Segment Performance

The U.S. Healthcare Solutions segment contributed significantly to revenue growth with $72.9 billion, while the International Healthcare Solutions segment saw revenues of $7.8 billion. Operating income increased in the U.S. segment but decreased in the International segment.

Summarized from source with an LLMView Source

Key figures

48.7%1Y

134%3Y

235%5Y

Performance

22.0%1Y

18.9%3Y

21.1%5Y

Volatility